“Norton Healthcare is proud to be the first health care provider in Kentucky to offer this important new advance that can help increase screening for colon cancer,” said Thomas M. Woodcock, MD, an oncology specialist with Norton Cancer Institute, according to the report.
More articles on gastroenterology:
FDA approves generic version of GERD treatment drug
Gilead Sciences to allow drug makers to make generic version of HCV treatment Sovaldi
US Endoscopy releases new Roth Net polyp retriever
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
